PYC ASX Chart
Snapshot
PYC Therapeutics (PYC) is a clinical-stage biotechnology company creating a new generation of RNA therapies to change the lives of patients with genetic diseases. The Company utilises its drug delivery platform to enhance the potency of precision medicines within the growing and commercially proven RNA therapeutic class. The Company was to progress a drug candidate for a blinding eye disease of childhood into human trials and is progressing multiple âfast-follower' programs into the clinic.
Share Price Activity (ASX)
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
Performance
1 Week | |
1 Month | |
2024 YTD | |
1 Year | |
vs Sector (1yr) | +73.57% |
vs ASX 200 (1yr) | +63.24% |
Latest PYC Therapeutics Ltd News
Announcements
Corporate Overview
Corporate Details
Head Office | Nedlands WA 6009 |
Website | www.pyctx.com |
Registry | Automic Group |
Auditor | PricewaterhouseCoopers |
Date Listed | 30 Mar 2005 |
Upcoming Calendar (Forecasted)
Date | Event |
---|---|
29/08/2024 | Report (Prelim) |
22/10/2024 | Report (Annual) |
27/02/2025 | Report (Interim) |
Former Company Names
- Phylogica Limited (PYC), 27/11/2019
Sponsored Financial Content
Dividend History
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
Directors & Management
Directors
Management
Director Transactions
PYC directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
Director Interests
The current holdings of PYC directors.
Shareholder Info
Substantial Shareholders
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Australian Land Pty Ltd | 15/04/2024 | 1,537,267,467 | 32.95 |
Sietsma Holdings Pty Ltd | 11/04/2024 | 283,400,000 | 6.07 |
Shareholders Buying
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
11-04-24 | Sietsma Holdings Pty Ltd | 95,010 | 7.60 | 6.07 |
26-03-24 | Australian Land Pty Ltd | 307,453,493 | 32.95 | 36.32 |
14-07-23 | Sietsma Holdings Pty Ltd | 4,278,765 | 8.96 | 7.72 |
14-07-23 | Australian Land Pty Ltd | 258,993,838 | 30.93 | 32.95 |
Shareholders Selling
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
30-04-24 | Malcolm Mccusker | 180,250,000 | 5.60 | -- |
22-05-23 | Anthony Barton | 155,200,314 | 5.30 | -- |
19-05-23 | Bhockings Private S/F 2 A/C | 199,835,396 | 6.30 | -- |
Historical Data
Share Price History
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Historical Data
Year | Closing Price | Last Trade |
---|---|---|
2023 | $0.056 | 30 June |
2022 | $0.065 | 30 June |
2021 | $0.155 | 30 June |
2020 | $0.115 | 30 June |
2019 | $0.029 | 28 June |
2018 | $0.026 | 29 June |
2017 | $0.043 | 28 June |
2016 | $0.013 | 28 June |
2015 | $0.021 | 30 June |
2014 | $0.012 | 30 June |
Important note:
All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.